Literature DB >> 8039526

Therapeutic traditions in type 2 diabetes--are they changing?

L Niskanen1, H Enlund, V Jormanainen, A Nissinen, M Uusitupa.   

Abstract

The utilisation of antidiabetic drugs reflects both the prevalence of diabetes and the different therapeutic traditions of physicians. A questionnaire survey to study attitudes to the use of oral antidiabetic drugs amongst physicians and possible changes in treatment habits was carried out in a representative sample of Finnish physicians (n = 454) in 1992 and the results were compared with those of a similar survey carried out in 1985, and with drug utilisation statistics. The mean fasting blood glucose level at which a physician would start pharmacological treatment was 8.7 mmol.l-1, which was significantly lower than in the 1985 survey. The responses to various case histories suggested a more active approach to pharmacological treatment compared to the 1985 survey. Insulin treatment especially seems to have gained in popularity. This change in attitude was paralled by an increase in the consumption of antidiabetic drugs in Finland during the observation period. The increase in use of oral drugs was steeper in Finland than in Norway and Sweden. Whether this active approach will improve the metabolic control and prognosis of patients with Type 2 diabetes, remains to be demonstrated.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8039526     DOI: 10.1007/bf00199870

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  7 in total

1.  Five-year follow-up study on plasma insulin levels in newly diagnosed NIDDM patients and nondiabetic subjects.

Authors:  L K Niskanen; M I Uusitupa; H Sarlund; O Siitonen; K Pyörälä
Journal:  Diabetes Care       Date:  1990-01       Impact factor: 19.112

2.  Changes in the prevalence and incidence of diabetes mellitus in Finnish adults, 1970-1987.

Authors:  M Laakso; A Reunanen; T Klaukka; A Aromaa; J Maatela; K Pyörälä
Journal:  Am J Epidemiol       Date:  1991-05-01       Impact factor: 4.897

3.  Therapeutic traditions in Northern Ireland, Norway and Sweden: I. Diabetes. WHO Drug Utilization Research Group (DURG).

Authors:  K Griffiths; D G McDevitt; M Andrew; I Baksaas; A Helgeland; J Jervell; P K Lunde; K Oydvin; I Agenäs; U Bergman
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

4.  Comparison of insulin regimens in patients with non-insulin-dependent diabetes mellitus.

Authors:  H Yki-Järvinen; M Kauppila; E Kujansuu; J Lahti; T Marjanen; L Niskanen; S Rajala; L Ryysy; S Salo; P Seppälä
Journal:  N Engl J Med       Date:  1992-11-12       Impact factor: 91.245

5.  The maintenance of improved metabolic control after intensified diet therapy in recent type 2 diabetes.

Authors:  M Uusitupa; J Laitinen; O Siitonen; E Vanninen; K Pyörälä
Journal:  Diabetes Res Clin Pract       Date:  1993-03       Impact factor: 5.602

6.  Metabolic control in diabetic subjects in three Swedish areas with high, medium, and low sales of antidiabetic drugs.

Authors:  J Stålhammar; U Bergman; K Boman; M Dahlén
Journal:  Diabetes Care       Date:  1991-01       Impact factor: 19.112

7.  Atherosclerotic vascular disease and its risk factors in non-insulin-dependent diabetic and nondiabetic subjects in Finland.

Authors:  M Laakso; T Rönnemaa; K Pyörälä; V Kallio; P Puukka; I Penttilä
Journal:  Diabetes Care       Date:  1988-06       Impact factor: 19.112

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.